Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Cash from Investing Activities (2016 - 2025)

KalVista Pharmaceuticals' Cash from Investing Activities history spans 10 years, with the latest figure at -$3.3 million for Q2 2025.

  • On a quarterly basis, Cash from Investing Activities rose 97.36% to -$3.3 million in Q2 2025 year-over-year; TTM through Apr 2025 was -$43.7 million, a 48.44% increase, with the full-year FY2025 number at $91.0 million, up 207.44% from a year prior.
  • Cash from Investing Activities hit -$3.3 million in Q2 2025 for KalVista Pharmaceuticals, down from $48.7 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for KALV hit a ceiling of $48.7 million in Q4 2024 and a floor of -$126.2 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$316000.0 across 3 years, with a median of $19.6 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 70.45% in 2024 and later soared 97.36% in 2025.
  • Tracing KALV's Cash from Investing Activities over 3 years: stood at $28.6 million in 2023, then skyrocketed by 70.45% to $48.7 million in 2024, then crashed by 106.84% to -$3.3 million in 2025.
  • Business Quant data shows Cash from Investing Activities for KALV at -$3.3 million in Q2 2025, $48.7 million in Q4 2024, and $37.2 million in Q3 2024.